Paper Details

  1. Home
  2. Paper Details

The Effects of Tranexamic Acid on Bleeding Control During and after Percutaneous Nephrolithotomy (PCNL): A Randomized Clinical Trial.

Author: AbediFarzad, FarshidSaman, ModresiParisa, MokhtariMohammad Reza

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Tranexamic acid reduced bleeding, blood transfusion needs, and hospitalization time in 108 patients undergoing percutaneous nephrolithotomy (PCNL).
Paper Details　
Original Abstract of the Article :
PURPOSE: Tranexamic acid is a fibrinolysis suppressor that is used for a variety of bleeding control procedures such as hematuria, surgery bleeding, and trauma caused bleeding. The advantages of using the tranexamic acid are bleeding control and less need for blood transfusion. MATERIALS AND METHOD...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/34291443

データ提供：米国国立医学図書館（NLM）

Tranexamic Acid: A Valuable Tool for Bleeding Control During PCNL

Percutaneous nephrolithotomy (PCNL), a surgical procedure to remove kidney stones, can lead to significant bleeding. This research investigates the effectiveness of tranexamic acid, a fibrinolysis suppressor, in controlling bleeding during and after PCNL. The researchers conducted a double-blind, randomized clinical trial comparing the effects of tranexamic acid with a placebo in patients undergoing PCNL. The study found that tranexamic acid significantly reduced bleeding during and after PCNL, leading to a shorter hospital stay for patients.

Tranexamic Acid: A Promising Adjunct for PCNL

This study demonstrates the value of tranexamic acid as an adjunct therapy for PCNL. The study found that tranexamic acid effectively reduced bleeding during and after surgery, leading to improved outcomes and a shorter recovery period for patients.

Minimizing Blood Loss: A Key Consideration in Surgery

Minimizing blood loss is a critical consideration in any surgical procedure. The use of tranexamic acid during PCNL represents a promising approach to reducing bleeding and improving patient outcomes.

Dr. Camel's Conclusion

Just as a camel can adapt to conserve water in the arid desert, managing bleeding during surgery is crucial for patient well-being. This research highlights the effectiveness of tranexamic acid in controlling bleeding during PCNL, leading to faster recovery times for patients. Remember, advances in surgical techniques and medications are constantly improving patient outcomes, offering a brighter future for those undergoing procedures like PCNL.
Date :
  1. Date Completed 2022-01-19
  2. Date Revised 2023-08-12
Further Info :

Pubmed ID

34291443

DOI: Digital Object Identifier

6505

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.